Skip to main content

SIGNIA: An innovative drug discovery platform for rapid identification and validation of antimicrobial applications in available pharmaceutical resources and drugs open for repurposing.

Project description

An innovative platform for faster, safer and cost-efficient drug discovery

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-1

Coordinator

SIGNIA THERAPEUTICS
Net EU contribution
€ 50 000,00
Address
L'atrium 43 Boulevard Du 11 Novembre 1918
69100 Villeurbanne
France

See on map

Region
Auvergne-Rhône-Alpes Rhône-Alpes Rhône
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 21 429,00